Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Bdrelin 3.75mg Injection
Manufacturer/Marketed By : BDR PHARMACEUTICALS INT PVT LTD
$71.88 $43.13
Bdrelin 3.75mg Injection contains an active component as Triptorelin. It is a medication that belongs to a class of drugs known as gonadotropin-releasing hormone (GnRH) analogs. It is primarily used...
Collapsible text is perfect for longer content like paragraphs and descriptions. It's a great way to give people more information while keeping your layout clean. Link your text to anything, including an external website or a different page. You can set your text box to expand and collapse when people click, so they can read more or less info.
TRIPTORELIN
Active Pharmaceutical Ingredient
Bdrelin 3.75mg Injection
71,88$
43,13$
Bdrelin 3.75mg Injection contains an active component as Triptorelin. It is a medication that belongs to a class of drugs known as gonadotropin-releasing hormone (GnRH) analogs. It is primarily used in the field of reproductive medicine for the treatment of various conditions related to hormonal imbalance. One of the most common use is in treating certain hormone-dependent conditions such as prostate cancer, breast cancer, and endometriosis. In prostate cancer, for example, this medication is used to lower the levels of testosterone, which can help slow down the growth of cancer cells. Bdrelin 3.75mg Injection should not be used in individuals who have a known hypersensitivity or allergic reaction to the medication or any of its components. The safety and effectiveness of this medication have not been established in children, so a healthcare professional will carefully consider and monitor its use in this population. Bdrelin 3.75mg Injection may have cardiovascular effects, including an increased risk of heart attack or stroke. It should be used cautiously in individuals with a history of cardiovascular disease or those at increased risk.
Active Pharmaceutical Ingredient
Uses
• Prostate cancer in men
• Early onset puberty in children 2 years of age and older (precocious puberty)
Benefits
Bdrelin 3.75mg Injection exerts its therapeutic effect by suppressing the release of luteinizing hormone (LH) and follicle-stimulating hormone (FSH) through its action on the pituitary gland. This suppression leads to a decrease in the production of sex hormones, such as testosterone and estrogen. By reducing the levels of these hormones, This medication is beneficial in treating hormone-dependent conditions such as prostate cancer, breast cancer, and endometriosis.
Side Effects
Bdrelin 3.75mg Injection cause some side effects like all medications, although not everyone will experience them.
Most Common Side Effects
• Hot flushes
• Weakness
• Excessive sweating
• Back pain
• Impotence
• Nausea
• Dry mouth
• Pain, bruising, redness at the injection site
• High blood pressure
• Weight gain
• Dizziness
• Headache
Common Side Effects
• Swallowing or breathing trouble
• Increased lymphocyte count in the blood
• Swelling of lips, tongue or throat
How To Use
Bdrelin 3.75mg Injection is typically administered via injection, either subcutaneously (under the skin) or intramuscularly (into the muscle). The specific dosing and frequency of administration will depend on the individual's condition being treated and their response to the medication. It is important to follow the healthcare professional's instructions regarding the administration technique and schedule.
Safety Advice
• Breast Feeding: The safety of Bdrelin 3.75mg Injection during breastfeeding is not well established. It is advisable to avoid using it while breastfeeding unless the potential benefits outweigh the potential risks to the nursing infant.
• Alcohol: The use of Bdrelin 3.75mg Injection in combination with alcohol is not well studied, and there is limited information available specifically regarding the interaction between this medication and alcohol. Therefore, it is generally recommended to exercise caution and avoid excessive alcohol consumption while using it.
• Liver: Bdrelin 3.75mg Injection should be used with caution in individuals with liver impairment or liver disease. The metabolism and elimination of this medication may be affected in such cases. However, there is limited information available specifically regarding the safety in patients with liver conditions.
• Lungs: Bdrelin 3.75mg Injection is generally considered safe for use in individuals with lung conditions. However, as with any medication, it is important to consult with a healthcare professional before starting this medication if you have a lung condition or any respiratory issues.
• Driving: Common side effects of Bdrelin 3.75mg Injection may include hot flashes, mood changes, and fatigue. If any of these side effects occur and significantly impact your alertness, concentration, or motor skills, it is advisable to avoid driving or operating machinery until you feel capable of doing so safely.
• Pregnancy: Bdrelin 3.75mg Injection is generally not recommended for use during pregnancy. If pregnancy is planned or suspected while using this medication, it is important to inform the healthcare professional promptly. They can provide appropriate guidance and make necessary adjustments to the treatment plan.
Disclaimer
Sidmex Inovia strives to provide accurate and reliable information; however, all content on this website, including product descriptions and compositions, is for informational purposes only and should not be considered a substitute for professional medical advice, diagnosis, or treatment.
Users are advised to consult a qualified healthcare professional before making any medical decisions. The information provided should not be used for self-diagnosis or self-medication.
All products listed are intended strictly for B2B and bulk inquiry purposes only. Sidmex Inovia does not promote direct consumer use and aims to support, not replace, the healthcare professional–patient relationship.
Product names, trademarks, and brands belong to their respective owners, and their use does not imply any affiliation or endorsement. Sidmex Inovia shall not be held responsible for any consequences arising from the use of the information provided on this website.